{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} AMSSM Scientific Statement Concerning Viscosupplementation Injections for Knee Osteoarthritis: Importance for Individual Patient Outcomes

Description

Osteoarthritis (OA) is a disabling disease that produces severe morbidity reducing physical activity. This article provides an evidence-based, best practices summary to assist physicians with the nonoperative treatment of OA and to establish the level of evidence, knowledge gaps, and areas requiring additional research.

Originally published in the January 2016 issue of Clinical Journal of Sports Medicine

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Purpose of Activity

To provide an evidence-based, best practices summary to assist physicians with the non-operative treatment of OA and to establish the level of evidence, knowledge gaps, and areas requiring additional research.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain the morbidity associated with osteoarthritis.
  2. Compare viscosupplementation hyaluronic acid (HA) treatment versus intra-articular corticosteroid (IAS) and intra-articular placebo Out(IAP) for osteoarthritis.
  3. Outline the Outcome Measures in Rheumatoid Arthritis Clinical Trials-osteoarthritis Research Society International (OMERACT-OARSI) criteria for treatment.
Price: FREE

Credits:

  • ACCME 2.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: CJSM0416
Published: April 2016
Expires: 1/1/2026
Required Passing Score: 7/10 (70%)
Authors: Thomas H. Trojian, MD, Andrew L. Concoff, MD, Susan M. Joy, MD, John R. Hatzenbuehler, MD, Whitney J. Saulsberry, PharmD, and Craig I. Coleman, PharmD
Categories: Sports Medicine
Topics: Osteoarthritis